Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
AJR Am J Roentgenol. 2012 Nov;199(5):1142-8. doi: 10.2214/AJR.11.7263.
The purposes of this study were to determine the performance of a new unenhanced MR angiography (MRA) sequence, spatial labeling with multiple inversion pulses (SLEEK), with regard to its ability to present the renal arteries and to reveal renal artery disease in patients with secondary hypertension.
Unenhanced MRA using SLEEK was performed on a 1.5-T MRI system for assessing renal arteries in 50 patients with hypertension. Then all patients underwent CT angiography (CTA) within 1-7 days. The ability to present the renal arteries and to reveal renal artery disease with SLEEK was evaluated by two experienced radiologists and was compared with CTA results using a joint reading performed in consensus.
Forty-six patients with hypertension successfully underwent SLEEK MRA. A total of 119 renal arteries were assessed, including 86 normal arteries, 26 with stenoses, and seven with fibromuscular dysplasia on CTA. There was excellent correlation between SLEEK and CTA in presenting the degree of renal artery stenosis (r(s) = 0.851; p < 0.05). SLEEK was superior to CTA in revealing the third- and fourth-order segmental branches in the renal parenchyma (p < 0.05). SLEEK has the advantage of avoiding interference from vertebra, atherosclerotic plaques, and early venous system enhancement.
Unenhanced MRA using SLEEK is a reliable diagnostic method for evaluating renal artery disease and revealing segmental branches in the renal parenchyma. It is relatively inexpensive and is not associated with renal complications. It can be used as an alternative to CTA for screening for renal artery disease, especially in patients with hypertension and renal insufficiency.
本研究旨在评估一种新的无需对比增强磁共振血管成像(MRA)序列——空间标记多重反转脉冲(SLEEK)在呈现肾动脉和揭示继发性高血压患者肾动脉疾病方面的性能。
在 1.5T MRI 系统上使用 SLEEK 对 50 例高血压患者的肾动脉进行 MRA 检查。然后所有患者在 1-7 天内行 CT 血管造影(CTA)检查。由两位有经验的放射科医生评估 SLEEK 呈现肾动脉和揭示肾动脉疾病的能力,并与 CTA 结果进行联合阅读以得出共识。
46 例高血压患者成功完成 SLEEK MRA。共评估了 119 条肾动脉,包括 CTA 显示的 86 条正常动脉、26 条狭窄动脉和 7 条纤维肌性发育不良动脉。SLEEK 与 CTA 在呈现肾动脉狭窄程度方面具有极好的相关性(r(s) = 0.851;p < 0.05)。SLEEK 在显示肾实质的三级和四级节段性分支方面优于 CTA(p < 0.05)。SLEEK 具有避免椎体、粥样斑块和早期静脉系统增强干扰的优势。
SLEEK 无需对比增强的 MRA 是一种评估肾动脉疾病和显示肾实质节段性分支的可靠诊断方法。它相对便宜,不会引起肾并发症。它可以作为 CTA 的替代方法用于筛查肾动脉疾病,特别是在高血压和肾功能不全的患者中。